• Explore /
  • Poster
  • / A prospective trial of apalutamide and abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer.

A prospective trial of apalutamide and abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer.

Abstract Poster

Authors

Daniel George

Daniel J. George

Duke Cancer Institute Center for Prostate and Urologic Cancers, Durham, NC

Daniel J. George , Susan Halabi , Mark T. Fleming , Elisabeth I. Heath , Ronald F. Tutrone , Linda Sutton , Young E. Whang , Brian E. Lewis , Michael Sandon Humeniuk , William R. Berry , Michael Roger Harrison , Julia Hurrelbrink , Kellie Shobe , Julia Rasmussen , Monika Anand , Marco Reyes-Martinez , Lauren Howard , Steven R. Patierno , Jennifer A Freedman , Andrew J. Armstrong

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer– Advanced/Castrate-Resistant

Clinical Trial Registration Number

NCT03098836

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 5015)

DOI

10.1200/JCO.2023.41.16_suppl.5015

Abstract #

5015

Poster Bd #

109

Abstract Disclosures

Similar Posters

First Author: Tanya B. Dorff

First Author: Soumyajit Roy

First Author: Morgan Goujon

First Author: Ronald C. Chen